{"result": "(\"entity\"<|>QUILOTÓRAX<|>EVENT<|>Quilotórax is a medical condition characterized by the accumulation of lymphatic fluid in the pleural cavity, often requiring treatment to manage fluid flow and nutritional support.)\n##\n(\"entity\"<|>ASCITIS<|>EVENT<|>Ascitis is the accumulation of fluid in the abdominal cavity, often associated with various medical conditions and requiring dietary and medical management.)\n##\n(\"entity\"<|>SISTEMA LINFÁTICO<|>ORGANIZATION<|>The lymphatic system is a network of tissues and organs that help rid the body of toxins, waste, and other unwanted materials, playing a crucial role in immune function.)\n##\n(\"entity\"<|>TRIGLICÉRIDOS<|>ORGANIZATION<|>Triglycerides are a type of fat (lipid) found in your blood, which the body uses for energy, and are significant in the context of dietary management for patients with certain medical conditions.)\n##\n(\"entity\"<|>ALBUMINA<|>ORGANIZATION<|>Albumin is a protein made by the liver that helps keep fluid in the bloodstream and is essential for maintaining blood volume and pressure.)\n##\n(\"entity\"<|>LINFOCITOS<|>ORGANIZATION<|>Lymphocytes are a type of white blood cell that are part of the immune system, playing a key role in defending the body against infections and diseases.)\n##\n(\"relationship\"<|>QUILOTÓRAX<|>ASCITIS<|>Quilotórax and ascites are both medical conditions involving fluid accumulation in the body, often requiring similar treatment approaches<|>7)\n##\n(\"relationship\"<|>SISTEMA LINFÁTICO<|>QUILOTÓRAX<|>The lymphatic system is directly involved in the development and management of quilotórax, as it relates to lymphatic fluid accumulation<|>8)\n##\n(\"relationship\"<|>SISTEMA LINFÁTICO<|>ASCITIS<|>The lymphatic system's function is relevant to ascites, as it plays a role in fluid balance and immune response<|>6)\n##\n(\"relationship\"<|>TRIGLICÉRIDOS<|>ALBUMINA<|>Triglycerides and albumin are both important in the context of nutritional management for patients with conditions like quilotórax and ascites<|>5)\n##\n(\"relationship\"<|>LINFOCITOS<|>SISTEMA LINFÁTICO<|>Lymphocytes are a key component of the lymphatic system, crucial for immune response<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ografía cuando el drenaje es\ninferior a 500 ml/día. La tomografía axial computariza-          Generalmente, el tratamiento de primera elección\nda generalmente permitirá identificar la localización y       será el tratamiento conservador, habitualmente por un\nlas causas secundarias4, 20.                                  tiempo limitado antes de iniciar medidas más invasivas.\n\n\n\n4.   Repercusión nutricional e inmunológica                   5.1.    Tratamiento conservador\n     de las lesiones del sistema linfático                       El tratamiento conservador del quilotórax y la ascitis\n   Los efectos sobre el estado nutricional dependen de        quilosa se dirige a reducir el flujo linfático basado en el\nla cantidad del flujo linfático, de la magnitud y dura-       drenaje adecuado, reposición de líquidos, dieta hiper-\nción de la lesión y del manejo nutricional del paciente4,     proteica, baja en grasa y suplementada con triglicéri-\n5, 21, 22 . En muchas ocasiones, los pacientes con alta sos-  dos de cadena media (TCM) o fórmulas sin grasa, nu-\npecha de presentar lesiones traumáticas o postquirúr-         trición enteral con preparados con alto contenido en\ngicas del sistema linfático permanecen en dieta absolu-       TCM o nutrición parenteral y tratamiento farmacológi-\nta, lo cual retrasa la aparición del quilotórax o la ascitis  co con somatostatina u octreotida. Según diferentes\nquilosa.                                                      estudios retrospectivos4, 5, 20-26, el tratamiento conserva-\n   El flujo linfático en condiciones normales puede os-       dor puede resolver entre el 70-80% de los quilotórax y\ncilar entre 2 a 4 litros al día (10-100 ml/kg/d), por lo      ascitis quilosa. La respuesta al tratamiento dependerá\nque una lesión importante del sistema linfático puede         de la causa subyacente. En la enteropatía perdedora de\nsuponer unas pérdidas de 2-2,5 litros al día con mani-        proteínas por linfangiectasia intestinal primaria el tra-\nfestaciones de hipovolemia, alteraciones electrolíticas,      tamiento dietético puede beneficiar al 67% de los pa-\nlas más frecuentes hiponatremia e hipocalcemia, aci-          cientes27. En otras situaciones, como las neoplasias, el\ndosis metabólica e inestabilidad hemodinámica. Si es-         beneficio del tratamiento dietético es mínimo por la\ntas son prolongadas van a conducir a una carencia de          mala tolerancia y difícil adherencia al mismo.\nproteínas, de las reservas de grasa y vitaminas, espe-\ncialmente las vitaminas liposolubles, A, D, E y K.            5.1.1.     Tratamiento dietético\n   La hipoproteinemia es debida a la pérdida de albú-\nmina, fibrinógeno e inmunoglobulinas. Esta depleción          5.1.1.1.     Dieta modificada en ácidos grasos\npuede dar lugar a trasvase de líquido al espacio inters-                   de cadena larga y ácidos grasos de\nticial con la aparición de edemas y dificultad para man-                   cadena media\ntener el volumen intravascular.\n   A toda esta situación hay que sumar un aumento de             La grasa contenida en los alimentos (grasa dietética)\nlas necesidades energéticas y proteicas a consecuencia        es una importante fuente de energía, que representa el\ndel traumatismo, cirugía o enfermedad subyacente.             30-40% del consumo energético diario. Más del 95% de\n   La repercusión sobre el sistema inmunológico deriva        la grasa dietética está compuesta por TCL, es decir trigli-\nde la pérdida de linfocitos, los cuales representan el        céridos compuestos por ácidos grasos de 14 o más car-\n95% del contenido celular del quilo. El 90% de estos          bonos. La absorción intestinal de estos TCL comporta\nlinfocitos son linfocitos T, mediadores de la inmunidad       una serie de fases: emulsificación, hidrólisis por las lipa-\ncelular, la cual quedará afectada, al igual que la inmu-      sas, solubilización e incorporación en micelas, absorción\nnidad humoral mediada por linfocitos B. Por otra par-         de los quilomicrones por el enterocito y paso a la linfa.\nte, el complemento y la función de los macrófagos                Contrariamente a estos, los TCM tienen una longitud\npermanecen normales. Los pacientes tienden a presen-          de cadena de 6 a 12 átomos de carbono. Las caracterís-\ntar anergia, linfopenia, hipoalbuminemia y descenso           ticas\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}